Synthimed Labs Private Limited

Company created at Chandigarh in 2023 which acquired the active ingredient and CRAMS business of Ind-Swift Laboratories and Essix Biosciences, along with the associated plants, customers and accreditations. It makes active ingredients in oncology, cardiovascular, anti-infectives, antidiabetics, antihistamines and antipsychotics, with a declared position in macrolide antibiotics. It declares around 3,000 employees.